KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Enterprise Value (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -9.70%
Dec 28, 2025 -8.30%
Sep 28, 2025 1.68%
Jun 29, 2025 51.32%
Mar 30, 2025 -58.15%
Dec 29, 2024 -20.82%
Sep 29, 2024 20.33%
Jun 30, 2024 2.83%
Mar 31, 2024 -14.35%
Dec 31, 2023 2.48%
Oct 1, 2023 13.71%
Jul 2, 2023 -10.69%
Apr 2, 2023 -10.47%
Jan 1, 2023 34.62%
Oct 2, 2022 -4.64%
Jul 3, 2022 -7.17%
Apr 3, 2022 3.86%
Jan 2, 2022 -1.96%
Oct 3, 2021 -22.50%
Jul 4, 2021 -2.79%
Apr 4, 2021 2.25%
Jan 3, 2021 18.18%
Sep 27, 2020 -60.86%
Jun 28, 2020 -6.16%
Mar 29, 2020 6.55%
Dec 29, 2019 -7.48%
Sep 29, 2019 -17.46%
Jun 30, 2019 0.38%
Mar 31, 2019 22.10%
Dec 30, 2018 -1.67%
Sep 30, 2018 -6.75%
Jul 1, 2018 -19.30%
Apr 1, 2018 16.90%
Dec 31, 2017 -12.72%
Oct 1, 2017 -26.28%
Jul 2, 2017 67.33%
Apr 2, 2017 6.12%
Jan 1, 2017 -3.65%
Oct 2, 2016 5.05%
Jul 3, 2016 -6.85%
Apr 3, 2016 -3.85%
Jan 3, 2016 -2.87%
Sep 27, 2015 -9.87%
Jun 28, 2015 -8.41%
Mar 29, 2015 5.35%
Dec 28, 2014 -0.25%
Sep 28, 2014 -4.37%
Jun 29, 2014 -7.59%
Mar 30, 2014 -0.64%
Dec 29, 2013 -15.77%
Sep 29, 2013 -0.39%
Jun 30, 2013 -15.97%
Mar 31, 2013 -2.75%
Dec 30, 2012 -6.67%
Sep 30, 2012 -16.88%
Jul 1, 2012 50.03%
Apr 1, 2012 -4.92%
Jan 1, 2012 -4.31%
Oct 2, 2011 -4.19%
Jul 3, 2011 -10.48%
Apr 3, 2011 2.86%
Jan 2, 2011 -25.00%
Oct 3, 2010 -17.06%
Jul 4, 2010 -4.95%
Apr 4, 2010 4.38%
Jan 3, 2010 -31.37%
Sep 27, 2009 2.58%
Jun 28, 2009 -16.90%